Can low serum carbon dioxide reflect hyperventilation-related respiratory alkalosis and autonomic overactivation?

Low serum carbon dioxide (hypocapnia) is a key physiological indicator that reflects systemic alterations in respiration, acid-base balance, and autonomic nervous system regulation.

Physiological mechanisms

• Respiratory alkalosis: Hyperventilation accelerates the exhalation of carbon dioxide, lowering arterial carbon dioxide tension ($PaCO_2$) and elevating blood pH.
• Renal compensation: In response to this pH shift, the kidneys downregulate hydrogen ion secretion and suppress bicarbonate ($HCO_3^-$) reabsorption. This compensatory excretion of bicarbonate results in a measurably low total serum carbon dioxide level on basic metabolic panels.
• Autonomic shift: Hypocapnia directly alters cardiac autonomic balance by suppressing parasympathetic (vagal) activity relative to sympathetic drive, shifting the body into a state of autonomic overactivation.

Clinical manifestations

• Palpitations and anxiety: Elevated sympathetic output and blunted parasympathetic control manifest clinically as palpitations. The physical sensations of hypocapnia—such as cerebral vasoconstriction and paresthesias—feed back into emotional centers to heighten anxiety, establishing a self-reinforcing panic-arousal loop.
• Sleep disruption: This persistent state of physiological hyperarousal disrupts sleep architecture. Chronic overbreathing and fluctuating respiratory drives prevent nocturnal relaxation, leading to fragmented sleep, sleep-maintenance insomnia, and nocturnal panic.

Bottom line

• Low serum carbon dioxide serves as a clear biomarker of respiratory alkalosis and autonomic overactivation. When interpreted alongside palpitations, anxiety, and sleep-maintenance insomnia, it reveals a coherent physiological pattern where hypocapnia-induced sympathetic dominance drives physical arousal, while neuropsychiatric tension concurrently perpetuates abnormal breathing.